LFST LifeStance Health Group Inc

Price (delayed)

$5.33

Market cap

$2.04B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.48

Enterprise value

$2.49B

Highlights
The company's gross profit rose by 30% YoY and by 8% QoQ
The revenue has grown by 21% YoY and by 4.5% from the previous quarter
The debt has grown by 6% YoY
LifeStance Health Group's equity has decreased by 5% YoY

Key stats

What are the main financial stats of LFST
Market
Shares outstanding
382.29M
Market cap
$2.04B
Enterprise value
$2.49B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.42
Price to sales (P/S)
1.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.26
Earnings
Revenue
$1.1B
EBIT
-$167.01M
EBITDA
-$43.51M
Free cash flow
-$68.73M
Per share
EPS
-$0.48
Free cash flow per share
-$0.18
Book value per share
$3.75
Revenue per share
$2.93
TBVPS
$1.61
Balance sheet
Total assets
$2.11B
Total liabilities
$677.32M
Debt
$502.85M
Equity
$1.43B
Working capital
$36.65M
Liquidity
Debt to equity
0.35
Current ratio
1.18
Quick ratio
1.09
Net debt/EBITDA
-10.42
Margins
EBITDA margin
-3.9%
Gross margin
29.7%
Net margin
-15.7%
Operating margin
-15.6%
Efficiency
Return on assets
-8.1%
Return on equity
-11.9%
Return on invested capital
-19.7%
Return on capital employed
-8.8%
Return on sales
-15.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LFST stock price

How has the LifeStance Health Group stock price performed over time
Intraday
-2.91%
1 week
3.29%
1 month
-2.56%
1 year
-39.02%
YTD
-31.93%
QTD
8.55%

Financial performance

How have LifeStance Health Group's revenue and profit performed over time
Revenue
$1.1B
Gross profit
$327.22M
Operating income
-$171.81M
Net income
-$173.12M
Gross margin
29.7%
Net margin
-15.7%
The company's gross profit rose by 30% YoY and by 8% QoQ
The net margin has grown by 24% YoY and by 11% from the previous quarter
The revenue has grown by 21% YoY and by 4.5% from the previous quarter
The operating margin has increased by 21% year-on-year and by 13% since the previous quarter

Growth

What is LifeStance Health Group's growth rate over time

Valuation

What is LifeStance Health Group stock price valuation
P/E
N/A
P/B
1.42
P/S
1.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.26
LFST's EPS is up by 8% year-on-year and by 6% since the previous quarter
LFST's price to book (P/B) is 25% lower than its last 4 quarters average of 1.9
LifeStance Health Group's equity has decreased by 5% YoY
The price to sales (P/S) is 33% less than the last 4 quarters average of 2.7
The revenue has grown by 21% YoY and by 4.5% from the previous quarter

Efficiency

How efficient is LifeStance Health Group business performance
LFST's return on invested capital is up by 30% year-on-year and by 10% since the previous quarter
LFST's return on sales is up by 24% year-on-year and by 14% since the previous quarter
LifeStance Health Group's return on assets has increased by 11% YoY and by 6% QoQ
LifeStance Health Group's return on equity has increased by 6% QoQ and by 3.3% YoY

Dividends

What is LFST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LFST.

Financial health

How did LifeStance Health Group financials performed over time
The quick ratio has grown by 8% from the previous quarter and by 6% YoY
LFST's current ratio is up by 6% QoQ
The debt is 65% less than the equity
The debt to equity has grown by 9% YoY but it has contracted by 2.8% from the previous quarter
The debt has grown by 6% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.